Business Day TV speaks to Stavros Nicolaou, a senior executive at Aspen
14 November 2024 - 20:54
byBusiness Day TV
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
GLP-1 drugs have grown in popularity and Aspen is betting on contracts for the medications to boost future earnings. To discuss the evolution of the highly effective diabetes and obesity drugs, Business Day TV sat down with Aspen’s Stavros Nicolaou.
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
NEWS LEADER
WATCH: Tracking the diabetes drug market
Business Day TV speaks to Stavros Nicolaou, a senior executive at Aspen
GLP-1 drugs have grown in popularity and Aspen is betting on contracts for the medications to boost future earnings. To discuss the evolution of the highly effective diabetes and obesity drugs, Business Day TV sat down with Aspen’s Stavros Nicolaou.
Companies in this Story
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Most Read
Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.